Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

Journal of Clinical Oncology - United States
doi 10.1200/jco.18.00454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

A Phase 2 Study of Alisertib (MLN8237) in Recurrent or Persistent Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study 0231D

Gynecologic Oncology
GynecologyOncologyObstetrics
2017English

Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

The Role of Racial Genetic Admixture With Endometrial Cancer Outcomes: An NRG Oncology/Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

Gynecologic Oncology Group Study 229C: Personal Reflection

Proceedings in Obstetrics and Gynecology
2013English

Associations Between Etiologic Factors and Mortality After Endometrial Cancer Diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 Trial

Gynecologic Oncology
GynecologyOncologyObstetrics
2015English

A Randomized Trial of Radiotherapy Versus Radiotherapy Plus CCNU for Incompletely Resected Low-Grade Gliomas: A Southwest Oncology Group Study

Journal of Neurosurgery
SurgeryNeurology
1993English

The Association Between Timing of Initiation of Adjuvant Therapy and the Survival of Early Stage Ovarian Cancer Patients – An Analysis of NRG Oncology/Gynecologic Oncology Group Trials

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

A Phase II Evaluation of Selumetinib (AZD6244, ARRY-142886), a Selective MEK-1/2 Inhibitor in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy